Trial Profile
A retrospective study to assess the effect of dimethyl fumarate on lymphocyte count in patients with multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 19 Nov 2016 New trial record